Validation of the Complexity Assessment and Monitoring to Ensure Optimal Outcomes (CAMEO II) Acuity Tool for Pediatric Critical Care Nursing.

Dimens Crit Care Nurs

Jean A. Connor, PhD, RN, CPNP, FAAN, is director of Nursing Research, Cardiovascular and Critical Care Nursing Patient Services, Boston Children's Hospital, and clinical instructor of pediatrics, Harvard Medical School, Boston, Massachusetts. Christine LaGrasta, DNP, RN, CPNP-PC/AC, is nurse practitioner II, Cardiac Acute Care Unit, Cardiovascular and Critical Care Nursing Patient Services, Boston Children's Hospital, Massachusetts. Kimberlee Gauvreau, ScD, is senior biostatistician, Department of Cardiology, Boston Children's Hospital, and associate professor, Department of Biostatistics, Harvard School of Public Health, Boston, Massachusetts. Courtney Porter, MPH, CPHQ, is program administrative manager II, Cardiovascular and Critical Care Nursing Patient Services, Boston Children's Hospital, Massachusetts. Patricia A. Hickey, PhD, MBA, RN, NEA-BC, FAAN, is vice president and associate chief nurse, Cardiovascular and Critical Care Nursing Patient Services, Boston Children's Hospital, and assistant professor of pediatrics, Harvard Medical School, Boston, Massachusetts.

Published: December 2019

Background: The Complexity Assessment and Monitoring to Ensure Optimal Outcomes (CAMEO II) acuity tool was developed to quantify patient acuity in terms of nursing cognitive workload complexity in a large, freestanding children's hospital in the United States.

Objectives: To describe the acuity and complexity of pediatric critical care nursing at a large children's hospital and correlate the CAMEO II with pediatric physiologic measures.

Methods: Construct validation was conducted correlating the CAMEO II to a pediatric classification system and 2 physiologic acuity tools. Descriptive statistics summarized patient characteristics. Construct validity across tools was evaluated using the Spearman correlation coefficient.

Results: CAMEO II was described both continuously and as ordinal complexity levels (I-V). Among 235 patients who completed CAMEO II across 4 intensive care units (ICUs), the mean total score was 99.06 (median, 97; range, 59-204). The CAMEO II complexity classification for 235 patients was as follows: I: 22 (9.4%), II: 53 (22.6%), III: 56 (23.8%), IV: 66 (28.1%), and V: 38 (16.2%). Findings from the 235 patients across the 4 ICUs revealed a significant correlation between the CAMEO II and the Therapeutic Intervention Scoring System-Children (ρ = 0.567, P < .001), CAMEO II and Pediatric Risk of Mortality III (ρ = 0.446, P < .001), and the CAMEO II and Score for Neonatal Acute Physiology Perinatal Extension II (ρ = 0.359, P = .013).

Discussion: Utilization of CAMEO II across ICUs provides an opportunity to validate the current complexity of pediatric critical care nursing in a large children's hospital.

Download full-text PDF

Source
http://dx.doi.org/10.1097/DCC.0000000000000355DOI Listing

Publication Analysis

Top Keywords

pediatric critical
12
critical care
12
care nursing
12
children's hospital
12
cameo pediatric
12
235 patients
12
cameo
11
complexity assessment
8
assessment monitoring
8
monitoring ensure
8

Similar Publications

Cholera rapid diagnostic tests (RDTs) are vulnerable to virulent bacteriophage predation. We hypothesized that an enhanced cholera RDT that detects the common virulent bacteriophage ICP1 might serve as a proxy for pathogen detection. We previously developed a monoclonal antibody (mAb) to the ICP1 major capsid protein.

View Article and Find Full Text PDF

Hypoalbuminemia as a predictor of severe dengue: a systematic review and meta-analysis.

Expert Rev Anti Infect Ther

January 2025

Center for Global Health Research, Saveetha Medical College and Hospital, Saveetha Institute of Medical and Technical Sciences, Saveetha University, Chennai, India.

Introduction: Dengue fever is a significant health concern globally, especially in tropical regions. Identifying reliable markers for severe dengue, such as hypoalbuminemia, is crucial for early diagnosis and treatment.

Methods: This review systematically explores the association between hypoalbuminemia and severe dengue.

View Article and Find Full Text PDF

The Portuguese Society of Ophthalmology and the Portuguese Society of Human Genetics developed clinical practice guidelines to streamline genetic testing for inherited retinal dystrophies (IRDs), underlining the critical role of molecular diagnosis in enhancing patient care. Genetic testing is pivotal in diagnosis, genetic counselling, prognosis and access to clinical trials, and new gene-specific therapies. These guidelines recommend genetic testing in all IRD patients and provide a detailed assessment of available testing methods, ensuring that genetic counselling is integrated into ophthalmic care.

View Article and Find Full Text PDF

Idiopathic pulmonary fibrosis (IPF) is etiologically complex, with well-documented genetic and nongenetic origins. In this Review, we speculate that the development of IPF requires two hits: the first establishes a vulnerable bronchoalveolar epithelium, and the second triggers mechanisms that reprogram distal epithelia to initiate and perpetuate a profibrotic phenotype. While vulnerability of the bronchoalveolar epithelia is most often driven by common or rare genetic variants, subsequent injury of the bronchoalveolar epithelia results in persistent changes in cell biology that disrupt tissue homeostasis and activate fibroblasts.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!